Advertisement
AMS vs THC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMS is a Hold and THC is a Hold.
Momentum Indicator for AMS turns negative, indicating new downward trend
AMS saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 135 similar instances where the indicator turned negative. In 99 of the 135 cases, the stock moved further down in the following days. The odds of a decline are at 73%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for AMS turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 33 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.
AMS moved below its 50-day moving average on September 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.
The Aroon Indicator for AMS entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AMS's RSI Oscillator exited the oversold zone, 8 of 9 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMS advanced for three days, in 133 of 205 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
AMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.368) is normal, around the industry mean (204.058). P/E Ratio (-4.923) is within average values for comparable stocks, (19.472). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (2.498). Dividend Yield (0.148) settles around the average of (0.099) among similar stocks. P/S Ratio (0.313) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. AMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Momentum Indicator for THC turns positive, indicating new upward trend
THC saw its Momentum Indicator move above the 0 level on October 07, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 77 similar instances where the indicator turned positive. In 64 of the 77 cases, the stock moved higher in the following days. The odds of a move higher are at 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for THC just turned positive on October 09, 2026. Looking at past instances where THC's MACD turned positive, the stock continued to rise in 33 of 44 cases over the following month. The odds of a continued upward trend are 75%.
THC moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for THC crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +3.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where THC advanced for three days, in 266 of 325 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The 10-day RSI Indicator for THC moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 55 similar instances where the indicator moved out of overbought territory. In 31 of the 55 cases, the stock moved lower in the following days. This puts the odds of a move lower at 56%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where THC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
THC broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for THC entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 16 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock better than average.
The Tickeron SMR rating for this company is 20 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. THC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.620) is normal, around the industry mean (204.058). P/E Ratio (10.255) is within average values for comparable stocks, (19.472). Projected Growth (PEG Ratio) (1.789) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.099) among similar stocks. P/S Ratio (1.022) is also within normal values, averaging (2.688).
AMS | THC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 41 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 4 Undervalued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 16 | |
SMR RATING 1..100 | 93 | 20 | |
PRICE GROWTH RATING 1..100 | 76 | 37 | |
P/E GROWTH RATING 1..100 | 26 | 65 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMS's Valuation (4) in the Medical Or Nursing Services industry is significantly better than the same rating for THC (74) in the Hospital Or Nursing Management industry. This means that AMS’s stock grew significantly faster than THC’s over the last 12 months.
THC's Profit vs Risk Rating (16) in the Hospital Or Nursing Management industry is significantly better than the same rating for AMS (100) in the Medical Or Nursing Services industry. This means that THC’s stock grew significantly faster than AMS’s over the last 12 months.
THC's SMR Rating (20) in the Hospital Or Nursing Management industry is significantly better than the same rating for AMS (93) in the Medical Or Nursing Services industry. This means that THC’s stock grew significantly faster than AMS’s over the last 12 months.
THC's Price Growth Rating (37) in the Hospital Or Nursing Management industry is somewhat better than the same rating for AMS (76) in the Medical Or Nursing Services industry. This means that THC’s stock grew somewhat faster than AMS’s over the last 12 months.
AMS's P/E Growth Rating (26) in the Medical Or Nursing Services industry is somewhat better than the same rating for THC (65) in the Hospital Or Nursing Management industry. This means that AMS’s stock grew somewhat faster than THC’s over the last 12 months.
| AMS | THC | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 89% | 4 days ago 56% |
| Stochastic ODDS (%) | 4 days ago 73% | 4 days ago 57% |
| Momentum ODDS (%) | 4 days ago 73% | 4 days ago 83% |
| MACD ODDS (%) | 4 days ago 73% | 4 days ago 75% |
| TrendWeek ODDS (%) | 4 days ago 62% | 4 days ago 80% |
| TrendMonth ODDS (%) | 4 days ago 65% | 4 days ago 78% |
| Advances ODDS (%) | 21 days ago 65% | 5 days ago 82% |
| Declines ODDS (%) | 8 days ago 64% | 19 days ago 66% |
| BollingerBands ODDS (%) | 4 days ago 78% | 4 days ago 57% |
| Aroon ODDS (%) | 4 days ago 68% | 4 days ago 73% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMS’s FA Score shows that 2 FA rating(s) are green while THC’s FA Score has 2 green FA rating(s).
- AMS’s FA Score: 2 green, 3 red.
- THC’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMS’s TA Score shows that 4 TA indicator(s) are bullish while THC’s TA Score has 5 bullish TA indicator(s).
- AMS’s TA Score: 4 bullish, 4 bearish.
- THC’s TA Score: 5 bullish, 5 bearish.
Price Growth
AMS (@Hospital/Nursing Management) experienced а -0.42% price change this week, while THC (@Hospital/Nursing Management) price change was -0.88% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -1.36%. For the same industry, the average monthly price growth was -6.61%, and the average quarterly price growth was +16.44%.
Reported Earning Dates
AMS is expected to report earnings on Nov 18, 2026.
THC is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Hospital/Nursing Management (-1.36% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
AMS and
Correlation & Price change
A.I.dvisor tells us that AMS and BKD have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMS and BKD's prices will move in lockstep.
| Ticker / NAME | Correlation To AMS | 1D Price Change % | ||
|---|---|---|---|---|
| AMS | 100% | -1.20% | ||
| BKD - AMS | 23% Poorly correlated | -2.28% | ||
| PNTG - AMS | 21% Poorly correlated | -2.89% | ||
| ADUS - AMS | 15% Poorly correlated | -0.71% | ||
| HCA - AMS | 14% Poorly correlated | -0.86% | ||
| THC - AMS | 11% Poorly correlated | -0.32% | ||
More | ||||
THC and
Correlation & Price change
A.I.dvisor indicates that over the last year, THC has been loosely correlated with HCA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if THC jumps, then HCA could also see price increases.